| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K44224150 |
| PharmacoGx | BRD-K44224150 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FBXO41 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.05 |
| mRNA | PRKACA | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | KIAA1551 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | TAF9B | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | RP11-618P17.4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | REN | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | CREB3L4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | GLT8D1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | HPF1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | RFC2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
